Literature DB >> 22015138

Rhodococcus equi pneumonia in the foal--part 1: pathogenesis and epidemiology.

Gary Muscatello1.   

Abstract

Rhodococcus equi pneumonia is a worldwide infectious disease of major concern to the equine breeding industry. The disease typically manifests in foals as pyogranulomatous bronchopneumonia, resulting in significant morbidity and mortality. Inhalation of aerosolised virulent R. equi from the environment and intracellular replication within alveolar macrophages are essential components of the pathogenesis of R. equi pneumonia in the foal. Recently documented evidence of airborne transmission between foals indicates the potential for an alternative contagious route of disease transmission. In the first of this two-part review, the complexity of the host, pathogen and environmental interactions that underpin R. equi pneumonia will be discussed through an exploration of current understanding of the epidemiology and pathogenesis of R. equi pneumonia in the foal.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22015138     DOI: 10.1016/j.tvjl.2011.08.014

Source DB:  PubMed          Journal:  Vet J        ISSN: 1090-0233            Impact factor:   2.688


  14 in total

Review 1.  Regulating the Intersection of Metabolism and Pathogenesis in Gram-positive Bacteria.

Authors:  Anthony R Richardson; Greg A Somerville; Abraham L Sonenshein
Journal:  Microbiol Spectr       Date:  2015-06

2.  Retrospective study of pneumonia in non-racing horses in California.

Authors:  Ariana Rahman; Francisco A Uzal; Anna M Hassebroek; Francisco R Carvallo
Journal:  J Vet Diagn Invest       Date:  2022-05-09       Impact factor: 1.569

3.  The effectiveness of anti-R. equi hyperimmune plasma against R. equi challenge in thoroughbred Arabian foals of mares vaccinated with R. equi vaccine.

Authors:  Osman Erganis; Zafer Sayin; Hasan Huseyin Hadimli; Asli Sakmanoglu; Yasemin Pinarkara; Ozgur Ozdemir; Mehmet Maden
Journal:  ScientificWorldJournal       Date:  2014-04-03

Review 4.  σ(ECF) factors of gram-positive bacteria: a focus on Bacillus subtilis and the CMNR group.

Authors:  Bianca Mendes Souza; Thiago Luiz de Paula Castro; Rodrigo Dias de Oliveira Carvalho; Nubia Seyffert; Artur Silva; Anderson Miyoshi; Vasco Azevedo
Journal:  Virulence       Date:  2014-06-12       Impact factor: 5.882

5.  Molecular characterization of Rhodococcus equi isolates from horses in Poland: pVapA characteristics and plasmid new variant, 85-kb type V.

Authors:  Lucjan Witkowski; Magdalena Rzewuska; Shinji Takai; Dorota Chrobak-Chmiel; Magdalena Kizerwetter-Świda; Małgorzata Feret; Marta Gawryś; Maciej Witkowski; Jerzy Kita
Journal:  BMC Vet Res       Date:  2017-01-26       Impact factor: 2.741

6.  Induction of Reactive Intermediates and Autophagy-Related Proteins upon Infection of Macrophages with Rhodococcus equi.

Authors:  Prashanth Chandramani-Shivalingappa; Mahesh Bhandari; Sarah A Wiechert; Jessica Gilbertie; Douglas E Jones; Brett A Sponseller
Journal:  Scientifica (Cairo)       Date:  2017-11-01

7.  Seroprevalence of <i>Rhodococcus equi</i> in horses in Israel.

Authors:  Sharon Tirosh-Levy; Sevil E Gürbilek; Osman Y Tel; Oktay Keskin; Amir Steinman
Journal:  J S Afr Vet Assoc       Date:  2017-06-26       Impact factor: 1.474

8.  Plasmid Profiles of Virulent Rhodococcus equi Strains Isolated from Infected Foals in Poland.

Authors:  Marcin Kalinowski; Zbigniew Grądzki; Łukasz Jarosz; Kiyoko Kato; Yu Hieda; Tsutomu Kakuda; Shinji Takai
Journal:  PLoS One       Date:  2016-04-13       Impact factor: 3.240

9.  An Adenoviral Vector Based Vaccine for Rhodococcus equi.

Authors:  Carla Giles; Olasumbo Ndi; Mary D Barton; Thiru Vanniasinkam
Journal:  PLoS One       Date:  2016-03-23       Impact factor: 3.240

10.  Oral Administration of Electron-Beam Inactivated Rhodococcus equi Failed to Protect Foals against Intrabronchial Infection with Live, Virulent R. equi.

Authors:  Joana N Rocha; Noah D Cohen; Angela I Bordin; Courtney N Brake; Steeve Giguère; Michelle C Coleman; Robert C Alaniz; Sara D Lawhon; Waithaka Mwangi; Suresh D Pillai
Journal:  PLoS One       Date:  2016-02-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.